BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 8021377)

  • 1. Margin control for lentigo maligna.
    Robinson JK
    J Am Acad Dermatol; 1994 Jul; 31(1):79-85. PubMed ID: 8021377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of lentigo maligna and lentigo maligna melanoma with paraffin-embedded tangential sections: utility of immunoperoxidase staining and supplemental vertical sections.
    Stonecipher MR; Leshin B; Patrick J; White WL
    J Am Acad Dermatol; 1993 Oct; 29(4):589-94. PubMed ID: 8408795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staged margin control techniques for surgical excision of lentigo maligna.
    Raziano RM; Clark GS; Cherpelis BS; Sondak VK; Cruse CW; Fenske NA; Glass LF
    G Ital Dermatol Venereol; 2009 Jun; 144(3):259-70. PubMed ID: 19528907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1.
    Kelley LC; Starkus L
    J Am Acad Dermatol; 2002 Jan; 46(1):78-84. PubMed ID: 11756950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of surgical margins for lentigo maligna versus melanoma in situ.
    Kunishige JH; Doan L; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2019 Jul; 81(1):204-212. PubMed ID: 31014825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins.
    Magro CM; Yang SE; Zippin JH; Zembowicz A
    Arch Pathol Lab Med; 2012 Dec; 136(12):1558-64. PubMed ID: 23194049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble adenylyl cyclase antibody (R21) as a diagnostic adjunct in the evaluation of lentigo maligna margins during slow Mohs surgery.
    Solky AC; Zembowicz A
    Am J Dermatopathol; 2014 Nov; 36(11):882-7. PubMed ID: 24698940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of teledermatopathology for intraoperative margin assessment of melanoma in situ, lentigo maligna type: A 6 year community practice experience.
    Emanuel PO; Patel R; Zwi J; Cheng D; Izzard M
    Eur J Surg Oncol; 2021 May; 47(5):1140-1144. PubMed ID: 32994100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of MITF and Melan-A Immunohistochemistry During Mohs Surgery for Lentigo Maligna-Type Melanoma In Situ and Lentigo Maligna Melanoma.
    Christensen KN; Hochwalt PC; Hocker TL; Roenigk RK; Brewer JD; Baum CL; Otley CC; Arpey CJ
    Dermatol Surg; 2016 Feb; 42(2):167-75. PubMed ID: 26771682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Micrographic surgery of lentigo maligna].
    van den Bos RR; Wakkee M; Koljenovil S; Nijsten T
    Ned Tijdschr Geneeskd; 2016; 160():A9827. PubMed ID: 27050497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma.
    Malhotra R; Chen C; Huilgol SC; Hill DC; Selva D
    Ophthalmology; 2003 Oct; 110(10):2011-8. PubMed ID: 14522781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision.
    Huilgol SC; Selva D; Chen C; Hill DC; James CL; Gramp A; Malhotra R
    Arch Dermatol; 2004 Sep; 140(9):1087-92. PubMed ID: 15381549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double Immunohistochemical Labelling of PRAME and Melan A in Slow Mohs Biopsy Margin Assessment of Lentigo Maligna and Lentigo Maligna Melanoma.
    Salih R; Ismail F; Orchard GE
    Br J Biomed Sci; 2024; 81():12319. PubMed ID: 38566933
    [No Abstract]   [Full Text] [Related]  

  • 14. Treating melanoma in situ and lentigo maligna with Mohs micrographic surgery in Australia.
    Foxton GC; Elliott TG; Litterick KA
    Australas J Dermatol; 2019 Feb; 60(1):33-37. PubMed ID: 29932208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate, optimal reconstruction of facial lentigo maligna and melanoma following total peripheral margin control.
    Jejurikar SS; Borschel GH; Johnson TM; Lowe L; Brown DL
    Plast Reconstr Surg; 2007 Oct; 120(5):1249-1255. PubMed ID: 17898597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines.
    Agarwal-Antal N; Bowen GM; Gerwels JW
    J Am Acad Dermatol; 2002 Nov; 47(5):743-8. PubMed ID: 12399768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of formalin-fixed Mohs surgery and haematoxylin and eosin stains with control contralateral biopsies for lentigo maligna: 5-year follow-up results.
    Lawrence CM; Rahim R; Charlton F; Husain A
    Br J Dermatol; 2014 Aug; 171(2):298-303. PubMed ID: 24446749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections.
    Cohen LM; McCall MW; Hodge SJ; Freedman JD; Callen JP; Zax RH
    Cancer; 1994 Jun; 73(12):2964-70. PubMed ID: 8199993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mohs' micrographic surgery using frozen sections alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ.
    Barlow RJ; White CR; Swanson NA
    Br J Dermatol; 2002 Feb; 146(2):290-4. PubMed ID: 11903242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience.
    Bhardwaj SS; Tope WD; Lee PK
    Dermatol Surg; 2006 May; 32(5):690-6; discussion 696-7. PubMed ID: 16706765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.